OTUD7B, a critical modulator of mTORC2 complexes, demonstrates significant suppression of KRAS‐driven tumour growth upon knockout [25], providing a theoretical foundation for developing selective deubiquitinase inhibitors. Here, KRAS is linked to neoplasm.